GlaxoSmithKline (GS71) Ownership - Who Owns GlaxoSmithKline?
GlaxoSmithKline (GS71) Ownership Overview
- 1.14% Insiders
- 12.21% Mutual Funds
- <0.01% Other Institutional Investors
- 15.06% ETFs
- 71.59% Public Companies and Individual Investors
The ownership structure of GlaxoSmithKline (CH:GS71) stock is a mix of institutional, retail, and individual investors. Approximately 27.27% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 71.59% is owned by Public Companies and Individual Investors.
The ownership structure of GlaxoSmithKline (CH:GS71) stock is a mix of institutional, retail, and individual investors. Approximately 27.27% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 71.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 23, 2026 | Maria Martinez-davis | $2,315,011 | |
| Jul 29, 2026 | Regis Simard | £774,440 | |
| Jun 22, 2026 | Jonathan Symonds | £29,996 | |
| Apr 28, 2026 | Wendy Becker | £78,516 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 227,170,849 | Institution | 5.62% | 7,201,088,742 |
| Vanguard | 163,805,086 | Institution | 4.05% | 5,192,457,421 |
| Dodge & Cox Funds | 70,688,840 | Institution | 1.75% | 2,240,765,539 |
| Ubs | 66,560,402 | Institution | 1.65% | 2,109,898,183 |
| Vanguard Star Funds | 58,754,184 | Institution | 1.45% | 1,862,448,879 |
| Vanguard Specialized Funds | 47,198,815 | Institution | 1.17% | 1,496,155,237 |
| Emma Walmsley | 42,643,517 | Insider | 1.05% | 1,351,756,845 |
| Vanguard Tax-managed Funds | 39,008,059 | Institution | 0.96% | 1,236,516,462 |
| Fidelity Salem Street Trust | 34,033,669 | Institution | 0.84% | 1,078,833,274 |
| Amundi | 29,390,126 | Institution | 0.73% | 931,637,604 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dodge & Cox Funds | 70,688,840 | Institution | 1.75% | 2,240,765,539 |
| Vanguard Star Funds | 58,754,184 | Institution | 1.45% | 1,862,448,879 |
| Vanguard Specialized Funds | 47,198,815 | Institution | 1.17% | 1,496,155,237 |
| Vanguard Tax-managed Funds | 39,008,059 | Institution | 0.96% | 1,236,516,462 |
| Fidelity Salem Street Trust | 34,033,669 | Institution | 0.84% | 1,078,833,274 |
| Vanguard International Equity Index Funds | 22,428,722 | Institution | 0.55% | 710,968,059 |
| Fidelity Concord Street Trust | 17,350,068 | Institution | 0.43% | 549,979,806 |
| Mfs Series Trust Xvii | 16,826,641 | Institution | 0.42% | 533,387,693 |
| Fidelity Rutland Square Trust Ii | 14,871,212 | Institution | 0.37% | 471,402,549 |
| Hartford Mutual Funds, Inc | 13,947,998 | Institution | 0.34% | 442,137,589 |
FAQ
Who Owns GlaxoSmithKline (CH:GS71)?
According to the latest TipRanks data, approximately 27.27% of the company's stock is held by institutional investors, 1.14% is held by insiders, and 71.59% is held by public companies and individual investors.
What percentage of GlaxoSmithKline (CH:GS71) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.27% of GlaxoSmithKline (CH:GS71) stock is held by institutional investors: 12.21% by mutual funds, 15.06% by ETFs and <0.01% by other institutional investors.
What percentage of GlaxoSmithKline (CH:GS71) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.59% of GlaxoSmithKline (CH:GS71) stock is held by public companies and individual investors.
Who owns the most shares of GlaxoSmithKline (CH:GS71)?
iShares owns the most shares of GlaxoSmithKline (CH:GS71).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.